Business Segment Information (Tables)

12 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Summary of Disaggregated Expense

In addition to the significant expense categories included within Consolidated Net Loss presented in the Company’s Consolidated Statements of Operations and Other Comprehensive Loss, see below for disaggregated expense amounts for the years ended March 31, 2026 and 2025 (in thousands):


	Year Ended				Year Ended
	March 31, 2026				March 31, 2025
Revenue
Royalty revenue	$	131			$	119
Product revenue		—				25
Total revenue		131				144
Operating expenses
Cost of revenues		—				5
Research and development (a) (b)		3,934				4,712
Selling, general, and administrative expenses (a)(b)		7,166				7,245
Non-cash stock-based compensation (see Note 6)		303				532
Depreciation and amortization (see Note 3)		215				266
Total operating expenses	$	11,618			$	12,760
Consolidated operating loss	$	(11,487	)		$	(12,616	)

(a) Stock-based compensation expense of $56,000 and $86,000 related to research and development and $247,000 and $446,000, related to selling, general, and administration have been excluded for the years ended March 31, 2026 and 2025, respectively.

(b) Depreciation and amortization expense of $199,000 and $227,000 related to research and development and $16,000 and $39,000 related to selling, general, and administration have been excluded for the years ended March 31, 2026 and 2025, respectively.